Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 20 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ABL1
💬1. ABL1
| 11件: ErbB signaling pathway ErbB signaling pathway, Ras signaling pathway, Cell cycle, Axon guidance, Neurotrophin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, MicroRNAs in cancer, Chemical carcinogenesis - reactive oxygen species, Chronic myeloid leukemia, Viral myocarditis 11件: ErbB signaling pathway, Ras signaling pathway, Cell cycle, Axon guidance, Neurotrophin signalin ... | Imatinib
Imatinib
💬1. ABL1
| Imatinib | 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬1. ABL1
| |||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
EDNRA
💬2. EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligan ... | Ambrisentan
Ambrisentan
💬2. EDNRA
| Ambrisentan | 7件: 51 51, 84, 85, 86, 88, 210, 211 💬
| |||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
EDNRA
💬3. EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligan ... | Macitentan
Macitentan
💬3. EDNRA
| Macitentan | 5件: 51 51, 85, 86, 88, 210 💬
| |||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
EDNRA
💬4. EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligan ... | Bosentan
Bosentan
💬4. EDNRA
| Bosentan | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬4. EDNRA
| |||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
EDNRA
💬5. EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligan ... | Bosentan
Bosentan
💬5. EDNRA
| Bosentan | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬5. EDNRA
| |||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
EDNRB
💬6. EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Macitentan
Macitentan
💬6. EDNRB
| Macitentan | 5件: 51 51, 85, 86, 88, 210 💬
| |||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
EDNRB
💬7. EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Bosentan
Bosentan
💬7. EDNRB
| Bosentan | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬7. EDNRB
| |||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
EDNRB
💬8. EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Bosentan
Bosentan
💬8. EDNRB
| Bosentan | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬8. EDNRB
| |||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
F10
💬9. F10
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Edoxaban
Edoxaban
💬9. F10
| Edoxaban | 2件: 46 46, 88 💬
| |||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
GUCY1A1
💬10. GUCY1A1
| 11件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Vascular smooth muscle contraction, Gap junction, Platelet activation, Circadian entrainment, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion 11件: Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Vascular smooth muscle contr ... | Riociguat
Riociguat
💬10. GUCY1A1
| Riociguat | 6件: 51 51, 84, 86, 88, 225, 299 💬
|